Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apollo Endosurgery Inc (NQ: APEN )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 9.990 (500)
Ask (Size) 10.00 (33)
Prev. Close 10.00
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 28,702,968
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
Via Benzinga
Analyzing Apollo Endosurgery's Short Interest
Apollo Endosurgery's (NASDAQ:APEN) short percent of float has fallen 63.08% since its last report. The company recently reported that it has 425 thousand shares sold short, which is 1.2% of all regular... 
Via Benzinga

Performance

More News

Read More
10 Best Stock Traders In Congress In 2022 (Spoiler: Nancy Pelosi Isn't No. 1)
Via Benzinga
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
Via ACCESSWIRE
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
Via Benzinga
Here's How Much $100 Invested In Apollo Endosurgery 5 Years Ago Would Be Worth Today
Via Benzinga
Apollo Endosurgery to be Acquired by Boston Scientific
Via ACCESSWIRE
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Apollo Endosurgery, Inc. (Nasdaq - APEN), Imago BioSciences, Inc. (Nasdaq - IMGO), Opiant Pharmaceuticals Inc. (Nasdaq - OPNT), Benefitfocus, Inc. (Nasdaq - BNFT)
From Brodsky & Smith LLC
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2022
Via Benzinga
APOLLO ENDOSURGERY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apollo Endosurgery, Inc. - APEN
From Kahn Swick & Foti, LLC
Via Business Wire
Investors Liked These 2 Stock Buyouts Tuesday
Via The Motley Fool
Nasdaq Down 50 Points; Crude Oil Rises Over 1%
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Apollo Endosurgery (NASDAQ: APEN) Enters Into Agreement to be Acquired by Boston Scientific (NYSE: BSX) for $615 Million
Via Spotlight Growth
Exposures Product Safety
Why Is Otonomy (OTIC) Stock Up 97% Today?
Via InvestorPlace
US Stocks Turn Lower; Dow Falls Over 100 Points
Via Benzinga
Bed Bath & Beyond (BBBY) Stock Rebounds After Black Friday Woes
Via InvestorPlace
Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific Deal
Via InvestorPlace
Why Shares Of Chinese Companies Are Trading Higher? Here Are 45 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
US Stocks Edge Higher Following Monday's Sell-Off
Via Benzinga
APEN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Apollo Endosurgery, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.
Via ACCESSWIRE
Apollo Endosurgery to Participate in Upcoming Investor Conferences
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.